AAAAAA

   
Results: 1-16 |
Results: 16
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease
Authors: Wagner, M Greten, FR Weber, CK Koschnick, S Mattfeldt, T Deppert, W Kern, H Adler, G Schmid, RM
Citation: M. Wagner et al., A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease, GENE DEV, 15(3), 2001, pp. 286-293
Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication
Authors: Dehde, S Rohaly, G Schub, O Nasheuer, HP Bohn, W Chemnitz, J Deppert, W Dornreiter, I
Citation: S. Dehde et al., Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication, MOL CELL B, 21(7), 2001, pp. 2581-2593
Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells
Authors: Utermohlen, O Schulze-Garg, C Warnecke, G Gugel, R Lohler, J Deppert, W
Citation: O. Utermohlen et al., Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells, J VIROLOGY, 75(22), 2001, pp. 10593-10602
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
Authors: Schulze-Garg, C Lohler, J Gocht, A Deppert, W
Citation: C. Schulze-garg et al., A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland, ONCOGENE, 19(8), 2000, pp. 1028-1037
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects
Authors: Behrend, L Milne, DM Stoter, M Deppert, W Campbell, LE Meek, DW Knippschild, U
Citation: L. Behrend et al., IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects, ONCOGENE, 19(47), 2000, pp. 5303-5313
Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53
Authors: Susse, S Janz, C Janus, F Deppert, W Wiesmuller, L
Citation: S. Susse et al., Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53, ONCOGENE, 19(39), 2000, pp. 4500-4512
Identification of genomic DNA sequences bound by mutant p53 protein (Gly(245)-> Ser) in vivo
Authors: Koga, H Deppert, W
Citation: H. Koga et W. Deppert, Identification of genomic DNA sequences bound by mutant p53 protein (Gly(245)-> Ser) in vivo, ONCOGENE, 19(36), 2000, pp. 4178-4183
Mutant p53: "Gain of function" through perturbation of nuclear structure and function?
Authors: Deppert, W Gohler, T Koga, H Kim, E
Citation: W. Deppert et al., Mutant p53: "Gain of function" through perturbation of nuclear structure and function?, J CELL BIOC, 2000, pp. 115-122
P53-dependent UVB responsiveness of human keratinocytes can be altered by cultivation on cell cycle-arrested dermal fibroblasts
Authors: Will, K Neben, M Schmidt-Rose, T Deppert, W Wittern, KP Bergemann, J
Citation: K. Will et al., P53-dependent UVB responsiveness of human keratinocytes can be altered by cultivation on cell cycle-arrested dermal fibroblasts, PHOTOCHEM P, 71(3), 2000, pp. 321-326
The dual role model for p53 in maintaining genomic integrity
Authors: Janus, F Albrechtsen, N Dornreiter, I Wiesmuller, L Grosse, F Deppert, W
Citation: F. Janus et al., The dual role model for p53 in maintaining genomic integrity, CELL MOL L, 55(1), 1999, pp. 12-27
TGF beta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression
Authors: Voss, M Wolff, B Savitskaia, N Ungefroren, H Deppert, W Schmiegel, W Kalthoff, H Naumann, M
Citation: M. Voss et al., TGF beta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression, INT J ONCOL, 14(1), 1999, pp. 93-101
Maintenance of genomic integrity by p53: complementary roles for activatedand non-activated p53
Authors: Albrechtsen, N Dornreiter, I Grosse, F Kim, E Wiesmuller, L Deppert, W
Citation: N. Albrechtsen et al., Maintenance of genomic integrity by p53: complementary roles for activatedand non-activated p53, ONCOGENE, 18(53), 1999, pp. 7706-7717
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53
Authors: Kim, E Rohaly, G Heinrichs, S Gimnopoulos, D Meissner, H Deppert, W
Citation: E. Kim et al., Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53, ONCOGENE, 18(51), 1999, pp. 7310-7318
Dissociation of the recombination control and the sequence-specific transactivation function of P53
Authors: Dudenhoffer, C Kurth, M Janus, F Deppert, W Wiesmuller, L
Citation: C. Dudenhoffer et al., Dissociation of the recombination control and the sequence-specific transactivation function of P53, ONCOGENE, 18(42), 1999, pp. 5773-5784
Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha
Authors: Kuhn, C Muller, F Melle, C Nasheuer, HP Janus, F Deppert, W Grosse, F
Citation: C. Kuhn et al., Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha, ONCOGENE, 18(3), 1999, pp. 769-774
Different regulation of the p53 core domain activities 3 '-to-5 ' exonuclease and sequence-specific DNA binding
Authors: Janus, F Albrechtsen, N Knippschild, U Wiesmuller, L Grosse, F Deppert, W
Citation: F. Janus et al., Different regulation of the p53 core domain activities 3 '-to-5 ' exonuclease and sequence-specific DNA binding, MOL CELL B, 19(3), 1999, pp. 2155-2168
Risultati: 1-16 |